Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-07-31

Clinical Trial Update: Recurrent Stroke Prevention Clinical Outcome Study [Phase 4]

View source ↗

Summary

A Phase 4 clinical outcome study on recurrent stroke prevention sponsored by Biomedis International Ltd is underway, focusing on hypertension and stroke; the cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Biomedis International Ltd. | Conditions: Hypertension, Stroke | Phase 4 | Status: UNKNOWN